Page last updated: 2024-11-08

amifampridine and Aura

amifampridine has been researched along with Aura in 2 studies

Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wirtz, PW1
Titulaer, MJ1
Gerven, JM1
Verschuuren, JJ1
Albowitz, B1
Kuhnt, U1
Ehrenreich, L1

Reviews

1 review available for amifampridine and Aura

ArticleYear
3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome.
    Expert review of clinical immunology, 2010, Volume: 6, Issue:6

    Topics: 4-Aminopyridine; Action Potentials; Amifampridine; Calcium Channels; Cholinergic Agents; Clinical Pr

2010

Other Studies

1 other study available for amifampridine and Aura

ArticleYear
Optical recording of epileptiform voltage changes in the neocortical slice.
    Experimental brain research, 1990, Volume: 81, Issue:2

    Topics: 4-Aminopyridine; Amifampridine; Animals; Bicuculline; Cerebral Cortex; Convulsants; Electrophysiolog

1990